FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira 5% Dextrose and 0 Recall

5% Dextrose and 0

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Jul 3, 2013
Recall ID
D-615-2013
Check your lot numberHow we source this data

Summary

Hospira recalled 5% Dextrose and 0 starting May 4, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-615-2013 on Jul 3, 2013. Reason: Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Product description

5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL VisIV Container, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7926-48

Lot numbers, UPCs & expiration codes

Lot #: 11-161-JT, Exp 11/13

Where it was sold

Nationwide Puerto Rico, U.S. Virgin Island, Libya, Saudi Arabia

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-615-2013
Classification
Class II
Status
Terminated
Recall initiated
May 4, 2012
FDA report date
Jul 3, 2013
Quantity
74,256 units
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-615-2013, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
61918
Address
275 N Field Dr
Code information
Lot #: 11-161-JT, Exp 11/13
Postal code
60045-2579
Report date
Jul 3, 2013
Product type
Drugs
Recall number
D-615-2013
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
74,256 units
Termination date
Jul 17, 2015
Reason for recall
Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.
Voluntary / mandated
Voluntary: Firm initiated
Product description
5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL VisIV Container, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7926-48
Distribution pattern
Nationwide Puerto Rico, U.S. Virgin Island, Libya, Saudi Arabia
Recall initiation date
May 4, 2012
Initial firm notification
Letter
Center classification date
Jun 21, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-615-2013, published Jul 3, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls